Danaher (DHR)
(Real Time Quote from BATS)
$269.06 USD
+0.25 (0.09%)
Updated Oct 9, 2024 03:55 PM ET
After-Market: $269.07 +0.01 (0.00%) 4:14 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$269.06 USD
+0.25 (0.09%)
Updated Oct 9, 2024 03:55 PM ET
After-Market: $269.07 +0.01 (0.00%) 4:14 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Zacks News
Danaher (DHR) Down 3.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
General Electric (GE) Arm Wins Wind Turbine Deal in Lithuania
by Zacks Equity Research
General Electric (GE) to offer 22 units of Cypress onshore wind turbines for European Energy's three wind farms.
Crane (CR) to Benefit From Buyouts and Growth Investments
by Zacks Equity Research
Crane (CR) stands to gain from the exposure in diverse end markets, acquired assets and cost reduction initiatives.
3M's (MMM) October Sales Increase Y/Y in Low-Single Digits
by Zacks Equity Research
3M's (MMM) sales performance in October is driven by gains from acquisitions/divestitures and healthy organic performance. Businesses in geographies flourish well.
5 Reasons Why Danaher (DHR) Stock is Worth Investing in Now
by Zacks Equity Research
Danaher (DHR) to benefit from healthy growth opportunities in Life Sciences and Diagnostics segments, acquired assets and shareholders-friendly policies.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
ITT Q3 Earnings and Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
ITT's third-quarter revenues decline 17% year over year on account of lackluster performance across its segments.
Honeywell (HON) Q3 Earnings & Revenues Top Estimates, Down Y/Y
by Zacks Equity Research
Honeywell (HON) third-quarter 2020 revenues decline 14% year over year on account of lackluster performance across most of its segments.
Surging Earnings Estimates Signal Upside for Danaher (DHR) Stock
by Zacks Equity Research
Danaher (DHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
General Electric (GE) Q3 Earnings Top Estimates, Decline Y/Y
by Zacks Equity Research
General Electric's (GE) third-quarter 2020 earnings beat estimates, while falling year over year on weak sales performance. Lower costs and expenses aid results.
3M (MMM) Q3 Earnings Beat Estimates, Fall Y/Y on High Costs
by Zacks Equity Research
3M's (MMM) third-quarter 2020 results reflect gains from higher sales generation as well as adverse impacts of higher costs and expenses, and taxes.
Crane (CR) Q3 Earnings & Revenues Surpass Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) third-quarter 2020 revenues decline 4.9% year over year on lackluster performance across its segments, except Payment & Merchandising Technologies.
5 Top Momentum Picks Screened on Driehaus Strategy
by Nitish Marwah
Richard Herman Driehaus created an investment approach using the buy high and sell higher theory.
Top Ranked Momentum Stocks to Buy for October 23rd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 23rd.
Danaher (DHR) Q3 Earnings Beat, Rise Y/Y on Sales Growth
by Zacks Equity Research
Danaher's (DHR) Q3 results reflect growth in Life Sciences and Diagnostics segments' sales, contribution from Cytiva, and operating margin rise. Core Q4 sales are likely to grow in high-single digits.
The Zacks Analyst Blog Highlights: Danaher Corp, PulteGroup, Penske Automotive, Mattel and Altra Industrial Motion Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher Corp, PulteGroup, Penske Automotive, Mattel and Altra Industrial Motion Corp
Danaher (DHR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 25.55% and 6.57%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Danaher (DHR)
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Carlisle (CSL) Q3 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Carlisle Companies' (CSL) third-quarter 2020 revenues decline 12% year over year on account of lackluster performance across its segments.
5 High-Flying Stocks With Room to Run on Q3 Earnings This Week
by Nalak Das
Five companies namely, Danaher (DHR), PulteGroup (PHM), Penske Automotive (PAG), Mattel (MAT) and Altra Industrial Motion (AIMC) with a favorable Zacks Rank are poised to beat earnings estimates this week.
Danaher (DHR) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
ITT vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
5 Spectacular Earnings Charts
by Tracey Ryniec
These popular stocks have some of the best earnings charts of the week.
The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher
Danaher (DHR) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Danaher's (DHR) Q3 results are expected to reflect a healthy demand for products in Life Sciences and Diagnostics segments. Also, Cytiva is anticipated to have aided core sales.